04/01/2015 - 10:54am

The cost of treating rheumatoid arthritis will reach $9.3 billion by 2020, according to a GBI Research report released Wednesday. 

03/30/2015 - 10:50am

Teva Pharmaceutical Industries and Auspex Pharmaceuticals announced an agreement under which Teva will acquire Auspex in a deal valued at $3.2 billion.

03/27/2015 - 2:17pm

More than 350 pharmacy advocates headed to Capitol Hill for the seventh annual NACDS RxIMPACT Day to further reinforce the recognition by lawmakers of the evolving role of pharmacy in patient care and educate members of Congress about pro-patient, pro-pharmacy policy.

03/25/2015 - 11:17am

Fred's acquired a specialty pharmacy operation for $66 million.

03/24/2015 - 10:02am

Diplomat Pharmacy commences follow-on public offering of 7.4 million shares of its common stock.

03/18/2015 - 11:51am

Diplomat Pharmacy to offer PARI’s cystic fibrosis treatment Kitabis Pak together with a PARI LC Plus nebulizer handset.

03/16/2015 - 11:27am

Diplomat Pharmacy is looking to raise $200 million with a proposed follow-on public offering of its common stock.

03/12/2015 - 1:53pm

CVS Health’s chief medical officer Troyen Brennan said in an interview with Reuters that the entry of copycat biotech drugs could cut prices of expensive medications by 40% to 50%.

03/12/2015 - 11:50am

Drug Channels Institute on Thursday listed the leading specialty pharmacy players.